|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Compensation Jumps 43 Pct for AbbVie (ABBV) CEO
3/19/2013 7:35:25 AM
The leader of drug maker AbbVie Inc. ( ABBV ) received total compensation valued at $7.9 million for 2012, up more than 40% from a year earlier. The compensation for AbbVie Chief Executive Richard A. Gonzalez was largely for his role as executive vice president of the pharmaceutical products group of Abbott Laboratories ( ABT ). AbbVie, which sells the blockbuster anti-inflammatory drug Humira, was spun out of Abbott Labs as an independent company on Jan. 1. Mr. Gonzalez, 59, received a salary of $863,942, stock awards valued at $3.3 million and a performance-based bonus of $2.5 million for his work in 2012, according to AbbVie's proxy statement filed Friday with the Securities and Exchange Commission. Mr. Gonzalez's annual bonus was based on the achievement by Abbott's pharmaceutical unit of several financial targets including adjusted earnings per share, sales and profit margins. In addition, he was rewarded for executing a commercial plan, bolstering the drug research-and-development pipeline, and helping to separate AbbVie from Abbott. Mr. Gonzalez's total compensation for 2012 was exceeded by another senior AbbVie officer: Laura J. Schumacher, who serves as general counsel and executive vice president of business development and external affairs. Ms. Schumacher received total compensation valued at $10.2 million for 2012, up more than 80% from 2011, according to the proxy.
|
|
|
|
|
|
|
|
|
|
|